Recent research investigates the potential benefits of combining smoking cessation medications, specifically varenicline with nicotine patches, and extending treatment durations. These strategies aim to enhance the effectiveness of quitting smoking.
Understanding these approaches can help healthcare providers and policymakers develop better interventions to support individuals in quitting smoking and reducing tobacco-related health risks.